PharmaDiversityJobBoard-Diversity Job Board connecting diversity & minority job seekers with Pharmaceutical jobs. Amgen (AMGN) Jobs
  Home  |  Job Seekers  |  Employers  |  FAQ  |  Contact Us    You're not logged in!
  Login  |  Job Search  |  Job Seeker Register  |  Employer Register  |  Translate:

Daiichi Sankyo Jobs

 
Click links to read Current News for this Featured Employer    Effient(R) Exhibited Greater Antiplatelet Activity than High Dose Clopidogrel in Type 2 Diabetes Mellitus Patients with Coronary Artery Disease | The Center for Medical Weight Loss Taps Weight Watchers Veteran to Serve as CEO | Welchol(R) (colesevelam HCl) Receives FDA Approval to Lower LDL Cholesterol in Pediatric Patients with Heterozygous Familial Hypercholesterolemia Welchol for Oral Suspension Also Approved by FDA | Survivors of Heart Events: What Does it Take to Get Back to Living? New program helps educate survivors of a heart event about the importance of maintaining good physical and emotional health | Ranbaxy Launches Authorized Generic Version of Rocaltrol(R) Agreement with Validus Pharmaceuticals to Market and Distribute Multiple Formulations in the U.S. Healthcare System | Ranbaxy Receives Final Approval To Market Sumatriptan Succinate Tablets Ranbaxy expands product portfolio by offering all strengths of Sumatriptan tablets | Effient(TM) is Now Available in Pharmacies Effient(TM) Reduces Thrombotic Cardiovascular Events in Patients with Acute Coronary Syndromes Managed with Common Artery-Opening Procedure | Analysis of Edoxaban Phase II Data Provides Insight Into Reduced Bleeding Events Seen in Once-Daily Dosing - Pharmacokinetic Analysis of Atrial Fibrillation Study May Explain Bleeding Rate Difference between Once-Daily and Twice-Daily Dosing Regimens with Same Total Exposure of Factor Xa Inhibitor - | Daiichi Sankyo and Lilly Receive U.S. FDA Approval for Effient(TM) Effient(TM) Reduces Thrombotic Cardiovascular Events in Patients with Acute Coronary Syndromes Managed with Common Artery-Opening Procedure | Nation's First Eco-Friendly Mobile Health Van Launched by New Jersey Non-Profit Health Center | Studiocom Continues Growth with Healthcare Industry Wins | Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial | Two Studies at AACE 2009 Annual Meeting Highlight Effects of Welchol(R) (colesevelam HCl) on Blood Glucose and LDL-C in Patients with Type 2 Diabetes | AZOR(R) Receives FDA Approval as First-Line Treatment for High Blood Pressure | Ongoing Landmark ROADMAP Study Demonstrates Significant Improvement in Blood Pressure Control at One Year, According to Blinded Results | New Data Shows Blood Pressure Reduction Therapy with BENICAR(R) and BENICAR HCT(R) Effectively Reduces Blood Pressure in Elderly Patients to Target Blood Pressure | New Data Shows AZOR(R) (amlodipine and olmesartan medoxomil) Significantly Improves 24-Hour Ambulatory Blood Pressure | New Analysis Evaluated Impact of Genetic Variation on Response to Prasugrel | The American Society of Hypertension Launches Education Program for Hypertension Accreditation | Smith & Nephew Introduces Metal Liner Option for the Modular R3(TM) Acetabular Cup System | Prasugrel Receives Unanimous Approval Recommendation from FDA Advisory Committee | Daiichi Sankyo, Inc. Establishes Subsidiary in Puerto Rico | Daiichi Sankyo Initiates Phase III Trial of Its Investigational Factor Xa Inhibitor, DU-176b, in Patients With Atrial Fibrillation | New Phase II Data Show Safety of Once-Daily Oral Factor Xa Inhibitor, DU-176b, Comparable to Warfarin in Patients With Non-Valvular Atrial Fibrillation | Daiichi Sankyo Initiates Phase III Trial of Its Investigational Factor Xa Inhibitor, DU-176b, in Patients With Atrial Fibrillation | New Phase II Data Show Safety of Once-Daily Oral Factor Xa Inhibitor, DU-176b, Comparable to Warfarin in Patients With Non-Valvular Atrial Fibrillation | Study Showed Prevention of Heart Attacks Within Three Months After Hospitalization Significantly Averted Future Heart Attacks and Death | Daiichi Sankyo and Lilly Respond to Speculation on Status of Prasugrel New Drug Application |
 
  
Items 1-25/108 displayed. [1-25][26-50][51-75][76-100][101-108] next
SaveDateJob TitleCity CountryStateCompany NamePay
Nov 15 District Manager, PC3 - Birmingham, AL
 Birmingham Alabama  Daiichi Sankyo Not specified
Nov 13 Manager, New Products Mktg Research CV & Diabetes
 Parsippany New Jersey  Daiichi Sankyo Not specified
Nov 12 Sales Representative, PC1 - Kalamazoo, MI
 Kalamazoo Michigan  Daiichi Sankyo Not specified
Nov 12 Sales Representative, PC3 - Pasadena, TX
 Pasadena Texas  Daiichi Sankyo Not specified
Nov 06 Sr. Manager, Managed Markets Training
 Parsippany New Jersey  Daiichi Sankyo Not specified
Nov 06 Sales Representative, PC3 - Little Rock S, AR
 Little Rock Arkansas  Daiichi Sankyo Not specified
Nov 06 Specialty Sales Representative, Roanoke, VA
 Roanoke Virginia  Daiichi Sankyo Not specified
Nov 06 Sales Representative, PC1 - Oklahoma City C, OK
 Oklohoma City Oklahoma  Daiichi Sankyo Not specified
Nov 06 Hospital Sales Representative, Jersey City, NJ
 Jersey City New Jersey  Daiichi Sankyo Not specified
Nov 06 Specialty Sales Representative, Oakland, CA
 Oakland California  Daiichi Sankyo Not specified
Nov 02 Sr. Analyst, Regional Market Analysis
 Parsippany New Jersey  Daiichi Sankyo Not specified
Nov 01 Clinical Study Manager
 Edison New Jersey  Daiichi Sankyo Not specified
Oct 29 Clinical Study Manager
 Edison New Jersey  Daiichi Sankyo Not specified
Oct 29 Clinical Study Manager
 Edison New Jersey  Daiichi Sankyo Not specified
Oct 29 Corporate Counsel
 Parsippany New Jersey  Daiichi Sankyo Not specified
Oct 28 Sales Representative, PC1 - Ann Arbor, MI
 Ann Arbor Michigan  Daiichi Sankyo Not specified
Oct 28 Sales Representative, PC3 - Vancouver, WA
 Vancouver Washington  Daiichi Sankyo Not specified
Oct 28 Specialty Sales Representative, Tulsa, OK
 Tulsa Oklahoma  Daiichi Sankyo Not specified
Oct 28 Specialty Sales Representative, Oak Park, IL
 Oak Park Illinois  Daiichi Sankyo Not specified
Oct 28 Sales Representative, PC2 - Providence, RI
 Providence Rhode Island  Daiichi Sankyo Not specified
Oct 28 Sales Representative, PC2 - Panama City, FL
 Panama City Florida  Daiichi Sankyo Not specified
Oct 26 Sales Representative, PC2 - Milwaukee S, WI
 Milwaukee Wisconsin  Daiichi Sankyo Not specified
Oct 26 Sales Representative, PC2 - Schaumburg, IL
 Schaumburg Illinois  Daiichi Sankyo Not specified
Oct 25 Sales Representative, PC3 - Kingsport, TN
 Kingsport Tennessee  Daiichi Sankyo Not specified
Oct 25 Sales Representative, PC1 - Las Vegas W, NV
 Las Vegas Nevada  Daiichi Sankyo Not specified